Spurious Drugs Case: Baddi Firm Owner Fails To Join Probe

Solan : Mukesh Saini, proprietor of Magnatek Enterprises, a pharmaceutical firm allegedly involved in the production of spurious drugs, failed to join the investigation at Baddi today.

The authorities sealed the unit on July 16 after seizing spurious drugs manufactured in violation of the Drugs and Cosmetics Act. The officials will inspect the premises in his presence.

CCTV footage obtained by drug officials showed him leaving the firm premises in a hurry around 8 pm on Sunday soon after a consignment was seized at the godown of a transport company.

He had reportedly received a call from the staff of the transport company about the seizure following which few other employees also made a hasty retreat on a bike while few lower-rung employees were left working in the unit.

Drugs Controller Navneet Marwaha said proprietor of Magnatek Enterprises Mukesh Saini failed to join the probe over the past two days. He has been granted the last opportunity tomorrow following which appropriate action would be taken against him.

With water-logging plaguing Delhi, the drug authorities are yet to verify whether a wholesale chemist in central Delhi had received any stock of spurious drugs manufactured at the Magnatek unit in the past.

Such a stock would be withdrawn from the market. The officials were verifying the other drug consignments sent by the firm to Chandigarh and other places.

It has been observed that wholesale traders from other states have direct links with the manufacturers at Baddi.

Related Posts

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

Stem cell therapy for autism illegal: NMC advisory

New Delhi:  The National Medical Commission (NMC) issued a strict advisory on March 25, 2026, declaring stem cell therapy illegal for treating Autism Spectrum Disorder and cerebral palsy in routine…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha